<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39365441</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-0407</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Der Nervenarzt</Title><ISOAbbreviation>Nervenarzt</ISOAbbreviation></Journal><ArticleTitle>[Post-COVID-19 condition-Clinical phenotyping in practice].</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00115-024-01753-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The high number and clinical heterogeneity of neurological impairments in patients with a post-COVID-19 condition (PCC) poses a challenge for outpatient care.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Our aim was to evaluate the applicability of the proposed subtypes according to the guidelines "Long/Post-COVID" (30 May 2024) and their phenotyping using clinical and neuropsychological findings from our post-COVID outpatient clinic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The evaluation was based on cross-sectional neurological and psychological test examinations of the patients, which were carried out using standardized questionnaires and test batteries. In addition, a detailed anamnesis of the current symptoms and a retrospective survey of the acute symptoms up to 4 weeks after the confirmed infection was conducted. The subtypes were classified according to the abovementioned guidelines based on the medical history and selected patient questionnaires, to which we added a 5th subtype with reference to the previous guidelines "Long/Post-COVID" (as of 5 March 2023).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 157 patients were included between August 2020 and March 2022. The presentation was at a median of 9.4 months (interquartile range, IQR = 5.3) after infection, with a mean age of 49.9 years (IQR = 17.2) and more women (68%) presenting, with a total hospitalization rate of 26%. Subtype 1 (postintensive care syndrome) showed the highest proportion of men, highest body mass index (BMI) scores and the highest rates of subjective complaints of word-finding difficulties (70%). Subtype 2 (secondary diseases) was dominated by cognitive impairment and had the highest depression scores. Subtype 3 (fatigue and exercise-induced insufficiency) was the most common, had the most symptoms and most severe subjective fatigue and the largest proportion of women. Subtype 4 (exacerbation) mainly showed affective symptoms. Subtype 5 (complaints without relevance to everyday life) had the lowest scores for depression, fatigue and BMI. Neurological and psychological conditions were frequently pre-existing in all groups.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The management of PCC can be improved at various levels. A standardized subtype classification enables early individually tailored treatment concepts. Patients at risk should be identified at the primary care level and informed about risk factors and prevention strategies. Regular monitoring of cardiovascular risk factors and physical activity are essential for PCC treatment. In the case of cognitive deficits and concurrent affective symptoms, psychotherapeutic support and drug treatment with selective serotonin reuptake inhibitors (SSRI) should be provided at an early stage.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Humkamp</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Klinik für Neurologie, Uniklinik RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Ana Sofia</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Klinik für Neurologie, Uniklinik RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reetz</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Klinik für Neurologie, Uniklinik RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walders</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Klinik für Neurologie, Uniklinik RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Deutschland. jwalders@ukaachen.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Post-COVID-19-Zustand – klinische Phänotypisierung in der Praxis.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Nervenarzt</MedlineTA><NlmUniqueID>0400773</NlmUniqueID><ISSNLinking>0028-2804</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="ger"><AbstractText Label="ZUSAMMENFASSUNG" NlmCategory="UNASSIGNED">HINTERGRUND: Die hohe Anzahl und klinische Heterogenität der neurologischen Beeinträchtigungen bei Patientinnen mit einem Post-COVID-19-Zustand (PCC) stellt eine Herausforderung für die ambulante Versorgung dar.</AbstractText><AbstractText Label="ZIEL DER ARBEIT" NlmCategory="UNASSIGNED">Unser Ziel war die Evaluation der Anwendbarkeit der vorgeschlagenen Subtypen gemäß der kürzlich aktualisierten Leitlinie „Long/Post-COVID“ (Stand 30.05.2024) und deren tiefere Phänotypisierung mittels klinisch und neuropsychologisch erhobener Befunde aus unserer neurologischen Post-COVID-Ambulanz.</AbstractText><AbstractText Label="METHODEN" NlmCategory="METHODS">Die Auswertung basierte auf querschnittlich erhobenen neurologischen und testpsychologischen Untersuchungen der Patientinnen, die mithilfe standardisierter Fragebögen und Testbatterien durchgeführt wurden. Außerdem fand eine eingehende Anamnese der aktuellen Symptomatik sowie die systematische retrospektive Erfragung der Akutsymptomatik bis 4 Wochen nach bestätigter Infektion statt. Die Einteilung der Subtypen erfolgte gemäß o. g. Leitlinie anhand der Anamnese, Vorbefunden sowie ausgewählter Patientenfragebögen. Zusätzlich wurde ein 5. Subtyp aus der vorangegangenen Leitlinie „Long/Post-COVID“ (Stand 05.03.2023) ergänzt.</AbstractText><AbstractText Label="ERGEBNISSE" NlmCategory="UNASSIGNED">Insgesamt wurden 157 Patientinnen zwischen August 2020 und März 2022 eingeschlossen. Die Vorstellung erfolgte im Median 9,4 Monate (IQR = 5,3) nach der Infektion, wobei das mediane Alter 49,9 Jahre (IQR = 17,2) betrug und 68 % weiblich waren, bei einer Hospitalisierungsrate von insgesamt 26 %. Subtyp 1 (Post-intensive-care-Syndrom) wies die höchste Männerquote und den höchsten Body-Mass-Index (BMI) sowie den größten Anstieg subjektiver Wortfindungsstörungen (70 %) auf. In Subtyp 2 (Folgekrankheiten) dominierten kognitive Beeinträchtigungen und die höchsten Depressionswerte. Subtyp 3 (Fatigue und Belastungsintoleranz) war am häufigsten (44 %), hatte den größten Frauenanteil, die meisten Symptome und die stärkste subjektive Fatigue. Subtyp 4 (Exazerbation einer Grunderkrankung) wies vor allem affektive Symptome auf. Subtyp 5 (Beschwerden ohne Alltagsrelevanz) hatte die niedrigsten Werte für Depression, Fatigue und BMI. Neurologische und psychische Erkrankungen waren überall häufig vorbestehend.</AbstractText><AbstractText Label="DISKUSSION" NlmCategory="CONCLUSIONS">Das Management eines PCC kann durch eine standardisierte Subtypeneinteilung, die individuelle und frühzeitige Behandlungskonzepte ermöglicht, verbessert werden. Risikopatientinnen sollten identifiziert und über Risikofaktoren sowie Präventionsstrategien aufgeklärt werden. Körperliche Aktivität und Reduzierung kardiovaskulärer Risikofaktoren sind essenziell. Bei kognitiven Defiziten und gleichzeitiger affektiver Symptomatik sollte zeitnah eine psychotherapeutische Anbindung und medikamentöse Behandlung mit selektiven Serotonin-Wiederaufnahme-Hemmern (SSRI) erfolgen.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Long-term effects</Keyword><Keyword MajorTopicYN="N">Neuropsychology</Keyword><Keyword MajorTopicYN="N">Subtypes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>11</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39365441</ArticleId><ArticleId IdType="doi">10.1007/s00115-024-01753-y</ArticleId><ArticleId IdType="pii">10.1007/s00115-024-01753-y</ArticleId></ArticleIdList><ReferenceList><Title>Literatur</Title><Reference><Citation>Andersen KM, Khan FL, Park PW et al (2024) Using a data-driven approach to define post-COVID conditions in US electronic health record data. PLoS ONE 19:e300570. https://doi.org/10.1371/journal.pone.0300570</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0300570</ArticleId><ArticleId IdType="pubmed">38578822</ArticleId><ArticleId IdType="pmc">10997091</ArticleId></ArticleIdList></Reference><Reference><Citation>Bungenberg J, Humkamp K, Hohenfeld C et al (2022) Long COVID-19: Objectifying most self-reported neurological symptoms. Ann Clin Transl Neurol 9:141–154. https://doi.org/10.1002/acn3.51496</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51496</ArticleId><ArticleId IdType="pubmed">35060361</ArticleId><ArticleId IdType="pmc">8862437</ArticleId></ArticleIdList></Reference><Reference><Citation>Coscia F, Di Filippo ES, Gigliotti PV et al (2023) Effect of physical activity on long COVID fatigue: an unsolved enigma. Eur J Transl Myol. https://doi.org/10.4081/ejtm.2023.11639</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/ejtm.2023.11639</ArticleId><ArticleId IdType="pubmed">37732339</ArticleId><ArticleId IdType="pmc">10583140</ArticleId></ArticleIdList></Reference><Reference><Citation>Coscia F, Mancinelli R, Gigliotti PV et al (2023) Physical Activity Effects on Muscle Fatigue in Sport in Active Adults with Long COVID-19: An Observational Study. Diagnostics (basel). https://doi.org/10.3390/diagnostics13071336</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13071336</ArticleId><ArticleId IdType="pubmed">37046554</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa AS, Balloff C, Bungenberg J et al (2023) Cognitive and neuropsychiatric trajectories up to one year after mild to severe COVID-19. Psychiatry Res 327:115375. https://doi.org/10.1016/j.psychres.2023.115375</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2023.115375</ArticleId><ArticleId IdType="pubmed">37523889</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagliati A, Strasser ZH, Hossein Abad ZS et al (2023) Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study. EClinicalMedicine 64:102210. https://doi.org/10.1016/j.eclinm.2023.102210</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102210</ArticleId><ArticleId IdType="pubmed">37745021</ArticleId><ArticleId IdType="pmc">10511779</ArticleId></ArticleIdList></Reference><Reference><Citation>Forgas JP (1995) Mood and judgment: the affect infusion model (AIM). Psychol Bull 117:39–66. https://doi.org/10.1037/0033-2909.117.1.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0033-2909.117.1.39</ArticleId><ArticleId IdType="pubmed">7870863</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentilotti E, Górska A, Tami A et al (2023) Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2023.102107</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102107</ArticleId><ArticleId IdType="pubmed">37654668</ArticleId><ArticleId IdType="pmc">10466236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghali A, Lacombe V, Ravaiau C et al (2023) The relevance of pacing strategies in managing symptoms of post-COVID-19 syndrome. J Transl Med 21:1–12. https://doi.org/10.1186/s12967-023-04229-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04229-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A et al (2023) True prevalence of long-COVID in a nationwide, population cohort study. Nat Commun 14:1–6. https://doi.org/10.1038/s41467-023-43661-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-43661-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera JE, Niehaus WN, Whiteson J et al (2021) Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV‑2 infection (PASC) patients. PM R 13:1027–1043. https://doi.org/10.1002/pmrj.12684</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12684</ArticleId><ArticleId IdType="pubmed">34346558</ArticleId><ArticleId IdType="pmc">8441628</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobi F, Höfler M, Siegert J et al (2014) Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the mental health module of the German health interview and examination survey for adults (DEGS1-MH). Int J Methods Psychiatr Res 23:304–319. https://doi.org/10.1002/mpr.1439</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mpr.1439</ArticleId><ArticleId IdType="pubmed">24729411</ArticleId><ArticleId IdType="pmc">6878234</ArticleId></ArticleIdList></Reference><Reference><Citation>Khraisat B, Toubasi A, AlZoubi L et al (2022) Meta-analysis of prevalence: the psychological sequelae among COVID-19 survivors. Int J Psychiatry Clin Pract 26:234–243. https://doi.org/10.1080/13651501.2021.1993924</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13651501.2021.1993924</ArticleId><ArticleId IdType="pubmed">34709105</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla AR et al (2024) S1-Leitlinie „Long/Post-Covid“. https://register.awmf.org/assets/guidelines/020-027l_S1_Long-Post-Covid_2024-06_1.pdf . Zugegriffen: 9. Juli 2024</Citation></Reference><Reference><Citation>Kuut TA, Müller F, Csorba I et al (2023) Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial. Clin Infect Dis 77:687–695. https://doi.org/10.1093/cid/ciad257</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad257</ArticleId><ArticleId IdType="pubmed">37155736</ArticleId><ArticleId IdType="pmc">10495128</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan ATH, Guo Z, Ceban F et al (2024) Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine. Adv Ther 41:1983–1994. https://doi.org/10.2147/NDT.S375294</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S375294</ArticleId><ArticleId IdType="pubmed">38520501</ArticleId></ArticleIdList></Reference><Reference><Citation>Legler F, Meyer-Arndt L, Mödl L et al (2023) Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort. EClinicalMedicine 63:102146. https://doi.org/10.1016/j.eclinm.2023.102146</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102146</ArticleId><ArticleId IdType="pubmed">37662515</ArticleId><ArticleId IdType="pmc">10469383</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Mattiuzzi C, Sanchis-Gomar F (2024) Physical Activity, Long-COVID, and Inactivity: A Detrimental Endless Loop. J Phys Act Health 21:420–422. https://doi.org/10.1123/jpah.2024-0057</Citation><ArticleIdList><ArticleId IdType="doi">10.1123/jpah.2024-0057</ArticleId><ArticleId IdType="pubmed">38467123</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg-Morris L, Leach S, Xu Y et al (2023) Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study. BMJ 383:e76990. https://doi.org/10.1136/bmj-2023-076990</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2023-076990</ArticleId><ArticleId IdType="pubmed">37993131</ArticleId><ArticleId IdType="pmc">10666099</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre RS, Phan L, Kwan ATH et al (2024) Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial. Brain 147:849–857. https://doi.org/10.1093/brain/awad377</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awad377</ArticleId><ArticleId IdType="pubmed">37936330</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE) (2020) COVID-19 rapid guideline: managing the long-term effects of COVID-19. London</Citation></Reference><Reference><Citation>Poletti S, Palladini M, Mazza MG et al (2022) Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life. Eur Arch Psychiatry Clin Neurosci 272:773–782. https://doi.org/10.1007/s00406-021-01346-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-021-01346-9</ArticleId><ArticleId IdType="pubmed">34698871</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuken PA, Besteher B, Finke K et al (2023) Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study. Eur Arch Psychiatry Clin Neurosci. https://doi.org/10.1007/s00406-023-01661-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-023-01661-3</ArticleId><ArticleId IdType="pubmed">37587244</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha JQS, Caputo EL, Vieira YP et al (2023) Physical activity status prevents symptoms of long covid: Sulcovid-19 survey. BMC Sports Sci Med Rehabil 15:1–7. https://doi.org/10.1186/s13102-023-00782-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13102-023-00782-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Rus CP, de Vries BEK, de Vries IEJ et al (2023) Treatment of 95 post-Covid patients with SSRIs. Sci Rep 13:1–17. https://doi.org/10.1038/s41598-023-45072-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-45072-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, Rathore SS, Khan H et al (2022) Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression. Front Endocrinol (lausanne) 13:780872. https://doi.org/10.1007/s00228-018-2593-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-018-2593-3</ArticleId><ArticleId IdType="pubmed">35721716</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S et al (2022) Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med 28:1706–1714. https://doi.org/10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId><ArticleId IdType="pmc">9388369</ArticleId></ArticleIdList></Reference><Reference><Citation>Tryfonos A, Pourhamidi K, Jörnåker G et al (2024) Functional Limitations and Exercise Intolerance in Patients With Post-COVID Condition: A Randomized Crossover Clinical Trial. Jama Netw Open 7:e244386. https://doi.org/10.1001/jamanetworkopen.2024.4386</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2024.4386</ArticleId><ArticleId IdType="pubmed">38573638</ArticleId><ArticleId IdType="pmc">11192186</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R et al (2023) Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern Med 183:566–580. https://doi.org/10.1001/jamainternmed.2023.0750</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId><ArticleId IdType="pmc">10037203</ArticleId></ArticleIdList></Reference><Reference><Citation>Wormgoor MEA, Rodenburg SC (2023) Focus on post-exertional malaise when approaching ME/CFS in specialist healthcare improves satisfaction and reduces deterioration. Front Neurol. https://doi.org/10.3389/fneur.2023.1247698</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1247698</ArticleId><ArticleId IdType="pubmed">38107643</ArticleId><ArticleId IdType="pmc">10722442</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B et al (2022) Long-term cardiovascular outcomes of COVID-19. Nat Med 28:583–590. https://doi.org/10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId><ArticleId IdType="pmc">8938267</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C, Huang WY‑J, Sun F‑H et al (2023) Association of Sedentary Lifestyle with Risk of Acute and Post-Acute COVID-19 Sequelae: A Retrospective Cohort Study. Am J Med. https://doi.org/10.1016/j.amjmed.2023.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.12.002</ArticleId><ArticleId IdType="pubmed">38110069</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C, Chen X‑K, Sit CH‑P et al (2024) Effect of Physical Exercise-Based Rehabilitation on Long COVID: A Systematic Review and Meta-analysis. Med Sci Sports Exerc 56:143–154. https://doi.org/10.1249/MSS.0000000000003280</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/MSS.0000000000003280</ArticleId><ArticleId IdType="pubmed">37586104</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>